or Try an Advanced Search...

    Biomarkers Stocks List

    Symbol Grade Name % Change
    IDYA F IDEAYA Biosciences, Inc. 0.71
    MYGN F Myriad Genetics, Inc. 2.45
    CGEN F Compugen Ltd. -2.76
    QTRX F Quanterix Corporation 0.26
    TTOO F T2 Biosystems, Inc. 19.77
    ACON F Aclarion, Inc. -1.73
    POAI F Predictive Oncology Inc. 4.50
    ANRO F Alto Neuroscience, Inc. 5.38
    CNTG F Centogene N.V. -9.09
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Health Information Services Medical Devices Medical Instruments & Supplies
    Related Stock Lists: Biotechnology Medicine Cancer Clinical Medicine Life Sciences Biopharmaceutical Cell Biology Chemical Pathology Diagnostic Tests Disease Medical Genetics Ovarian Cancer Pharmaceutical Precision Medicine Targeted Therapy Whole Blood Antibodies Antibody Antibody Therapy Artificial Intelligence

    Related ETFs - A few ETFs which own one or more of the above listed Biomarkers stocks.

    Symbol Grade Name Weight
    PBE C PowerShares Dynamic Biotech & Genome 4.39
    GNOM F Global X Genomics & Biotechnology ETF 2.74
    PINK D Simplify Health Care ETF 1.98
    RJMG A FT Raymond James Multicap Growth Equity ETF 1.74
    OZEM F Roundhill GLP-1 & Weight Loss ETF 1.72
    View all Biomarkers ETFs...
    Compare ETFs
    Compare GNOM to RJMG Compare PBE to GNOM Compare PINK to OZEM

        Biomarkers Stocks Recent News

        Date Stock Title
        Nov 22 IDYA Ideaya Biosciences Inc. (IDYA): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts
        Nov 21 ACON Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash
        Nov 20 MYGN Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
        Nov 19 MYGN Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy
        Nov 19 MYGN Myriad Genetics price target lowered to $21 from $32 at Morgan Stanley
        Nov 18 IDYA IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Health Information Services Medical Devices Medical Instruments & Supplies
        Related Stock Lists: Biotechnology Cancer Medicine Biology Clinical Medicine Diagnostic Tests Life Sciences Alzheimer's Disease Biomarker Technology Cell Biology Chemical Pathology Disease Drug Discovery Heart Disease Infectious Diseases Medical Genetics Medical Test Molecular Diagnostics Neurology Ovarian Cancer
        Biomarkers

        A biomarker, or biological marker is a measurable indicator of some biological state or condition. Biomarkers are often measured and evaluated to examine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers are used in many scientific fields.

        More about Biomarkers
        Browse All Tags